For a free consultation call us on 0151 669 1112
Contact Us 0151 669 1112

Contact Us

Fill in the form to contact us by email. Fields marked with * are required

Address: Liverpool Laser Clinic
20 Knight Street
(off Rodney Street)
Liverpool
L1 9DS
Telephone: 0151 669 1112 Fax: 0845 643 0209

Book A Consultation

Fill in the form to contact us by email. Fields marked with * are required

Cellulaze – Laser Cellulite Treatment

Cellulaze is the world's first minimally invasive laser cellulite treatment to address the core structure of cellulite. It was introduced to the market after four years of intense research on a clinical study which involved 120 patients in USA. Cellulaze received the European approval in January 2011 and the FDA (American Food and Drug Administration) approval in January 2012. Cellulaze was officially launched in UK in September 2011.  In July 2011, Liverpool Laser Clinic introduced the new technique to UK when Mr Hassan Shaaban performed the first Cellulaze treatment.

Cellulaze is unique in that it attacks the three different structural components of cellulite. The three components of cellulite are:

  1. Proliferation of fat cells within their tight compartments appearing as skin bulges
  2. Shortening of skin septae (links between skin and muscles) causing dimpling of the skin
  3. Loss of skin thickness and elasticity, resulting in an uneven skin appearance

Cellulaze delivers a laser beam under the skin through two to three small incisions.  It treats all components of cellulite at the same setting.  It dissolves fat bulges, divides fibrous band to release skin dimples and also tightens the skin through stimulation of collagen formation. Cellulaze gives a long-lasting result after a single treatment. Follow up of early cases of Cellulaze in USA shows no recurrence of cellulite after three years of treatment.

The Cellulaze laser is unique in that it produces a combination of different laser wavelengths. One particular wave length (Nd-YAG 1064nm) targets blood vessels under the skin, reducing bleeding and resulting in less post-op bruising, pain and swelling.

Mr Shaaban explains: “In my opinion, the main structural abnormality of cellulite lies in the unexplained shortening of the fibrous septae between the skin and deeper muscles, as well as the laxity of the skin. None of the existing treatments have been able to address these problems adequately and, as a result, as plastic surgeons, we have been unable to produce satisfactory results.”

Cellulaze is different from any currently available cellulite treatment. Creams and lotions have minimal effect on cellulite. Very few may stimulate the skin to produce collagen but they have no effect on fat bulges or skin dimples. Also, they have to be used daily and for a long time to get any result. External cellulite therapy like ultrasound, radiofrequency, external laser and Endermologie has limited success as most of these techniques stimulate the skin to produce collagen, some can dissolve some fat but none has any effect on the fibrous bands (skin dimples). They also need to be applied frequently (may be weekly) to maintain any effect.

The Cellulaze workstation has two unique safety devices (ThermaGuide and SmartSense) to ensure maximum clinical safety. The ThermaGuide measures the temperature under the skin, which allows the surgeon to maintain the temperature at the optimum level required to produce skin tightening, whilst at the same time reducing the risk of excessive heating and burns.

The Smart-Sense is a motion sensing device which controls the amount of energy delivered, according to how fast the probe is moved by the surgeon. This produces the most even heating of the skin and reduces the risk of delivering excessive energy in one spot, which can result in tissue necrosis.

Mr Shaaban presented the results of his first 12 cases of Cellulaze at the recent meeting of the British Association of Aesthetic and Plastic Surgeons (BAAPS 2012). All patients were female aged between 23yrs and 56yrs. All cases were performed as walk-in walk-out procedure under local anaesthesia. Six patients had Cellulaze treatment combined with Laser Assisted Liposuction (LAL). Four patients had multiple stages treatment (each stage is the size of A4 paper sheet). All patients showed much improvement in the appearance of their cellulite with a high patient satisfaction rate.

Up to date, Cellulaze proved to be an effective safe technique to treat the dread orange-peel appearance of cellulite. It needs a single minimally invasive treatment but shows immediate results which continues to improve with time.

Cellulaze is the world's first minimally invasive laser cellulite treatment to address the core structure of cellulite. It was introduced to the market after four years of intense research on a clinical study which involved 120 patients in USA. Cellulaze received the European approval in January 2011 and the FDA (American Food and Drug Administration) approval in January 2012. Cellulaze was officially launched in UK in September 2011.  In July 2011, Liverpool Laser Clinic introduced the new technique to UK when Mr Hassan Shaaban performed the first Cellulaze treatment.

Cellulaze is unique in that it attacks the three different structural components of cellulite. The three components of cellulite are:

  1. Proliferation of fat cells within their tight compartments appearing as skin bulges
  2. Shortening of skin septae (links between skin and muscles) causing dimpling of the skin
  3. Loss of skin thickness and elasticity, resulting in an uneven skin appearance

Cellulaze delivers a laser beam under the skin through two to three small incisions.  It treats all components of cellulite at the same setting.  It dissolves fat bulges, divides fibrous band to release skin dimples and also tightens the skin through stimulation of collagen formation. Cellulaze gives a long-lasting result after a single treatment. Follow up of early cases of Cellulaze in USA shows no recurrence of cellulite after three years of treatment.

The Cellulaze laser is unique in that it produces a combination of different laser wavelengths. One particular wave length (Nd-YAG 1064nm) targets blood vessels under the skin, reducing bleeding and resulting in less post-op bruising, pain and swelling.

Mr Shaaban explains: “In my opinion, the main structural abnormality of cellulite lies in the unexplained shortening of the fibrous septae between the skin and deeper muscles, as well as the laxity of the skin. None of the existing treatments have been able to address these problems adequately and, as a result, as plastic surgeons, we have been unable to produce satisfactory results.”

Cellulaze is different from any currently available cellulite treatment. Creams and lotions have minimal effect on cellulite. Very few may stimulate the skin to produce collagen but they have no effect on fat bulges or skin dimples. Also, they have to be used daily and for a long time to get any result. External cellulite therapy like ultrasound, radiofrequency, external laser and Endermologie has limited success as most of these techniques stimulate the skin to produce collagen, some can dissolve some fat but none has any effect on the fibrous bands (skin dimples). They also need to be applied frequently (may be weekly) to maintain any effect.

The Cellulaze workstation has two unique safety devices (ThermaGuide and SmartSense) to ensure maximum clinical safety. The ThermaGuide measures the temperature under the skin, which allows the surgeon to maintain the temperature at the optimum level required to produce skin tightening, whilst at the same time reducing the risk of excessive heating and burns.

The Smart-Sense is a motion sensing device which controls the amount of energy delivered, according to how fast the probe is moved by the surgeon. This produces the most even heating of the skin and reduces the risk of delivering excessive energy in one spot, which can result in tissue necrosis.

Mr Shaaban presented the results of his first 12 cases of Cellulaze at the recent meeting of the British Association of Aesthetic and Plastic Surgeons (BAAPS 2012). All patients were female aged between 23yrs and 56yrs. All cases were performed as walk-in walk-out procedure under local anaesthesia. Six patients had Cellulaze treatment combined with Laser Assisted Liposuction (LAL). Four patients had multiple stages treatment (each stage is the size of A4 paper sheet). All patients showed much improvement in the appearance of their cellulite with a high patient satisfaction rate.

Up to date, Cellulaze proved to be an effective safe technique to treat the dread orange-peel appearance of cellulite. It needs a single minimally invasive treatment but shows immediate results which continues to improve with time.